Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers V > Headlines for Venus Remedies Ltd. > News item |
Venus Remedies approved to launch cephalosporin product for pneumonia in India
By Lisa Kerner
Charlotte, N.C., Aug. 16 - Venus Remedies Ltd said the Drug Controller General of India has approved its launch of cephalosporin in combination with an amino-glycoside for the treatment of hospital-acquired pneumonia, following completion of clinical trials.
The company plans to market the fixed-dose combination drug in India and worldwide, according to a news release.
Venus, based in Haryana, India, specializes in anticancer medicines, cephalosporin and carbapenem injectables.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.